Company Data
Avalo Therapeutics Inc.
Ticker
AVTX
Current Price
$17.645 -3.89%
Market Cap
$326.7M
Price Target
Refer to Report
Volume
1.0M
52wk Range
$3.39 - $20.7199
Overview
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.